Evaluating plasma antinuclear autoantibody profile as a prognostic biomarker in lymphoma
Our study evaluated ANA profile in various subtypes of lymphoma and demonstrated the prognostic value of autoantibodies in predicting clinical outcomes. The results highlight the potential of incorporating ANA profile into the prognostic assessment of lymphoma.
Authors
- Xiaohong Han (ORCID: https://orcid.org/0000-0001-9190-0167)
- Yanrong Wang (ORCID: https://orcid.org/0000-0002-2277-9671)
- Ruyun Gao (ORCID: https://orcid.org/0009-0004-3683-8734)
- Cuiling Zheng
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1186/s12885-024-13198-2
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China